Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.
about
Transcriptional Targeting in Cancer Gene TherapyAdvances in preclinical investigation of prostate cancer gene therapy.A novel oncolytic adenovirus based on simian adenovirus serotype 24Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenovirusesTissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathwayA novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.Experimental models to study lymphatic and blood vascular metastasis.Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cellsConditionally replicating adenoviruses for cancer treatment.Oncolytic viruses in the treatment of bladder cancerSpecific targeting of gene therapy to prostate cancer using a two-step transcriptional amplification systemSelectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.Comparison of prostate-specific promoters and the use of PSP-driven virotherapy for prostate cancer.Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes.Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter.Evaluation of vesicular stomatitis virus mutant as an oncolytic agent against prostate cancer.Targeting strategies of adenovirus‑mediated gene therapy and virotherapy for prostate cancer (Review).Review: Oncolytic virotherapy, updates and future directions.
P2860
Q24791038-0680676F-D3E0-48D9-A468-E6385E8EBCB2Q33677054-939091A2-D934-4862-AC44-ACDCE003F88EQ33688856-B25D1082-7E4F-4B87-8B10-35B7103D446AQ33755007-75B47832-0137-4A4C-A1F0-127D958D72FBQ33838380-220A4A8A-CE3A-4170-9066-F6ACE4626DF1Q33865835-B31AC43F-75AD-482B-9E75-FFECD34B2ACBQ34036427-AB90D12A-F1ED-498C-BC39-DA03FBC115F8Q35446777-13FF947B-58CB-4CE6-8448-7ED1F86A15FEQ35598835-4AA1C536-EB12-4E6B-BC4B-6686320BE2C9Q35967313-69F77A26-6D8D-4FAA-BC10-360E04E574E0Q36147934-A5997458-F26F-4A22-B819-B199631FC879Q36512533-7B3748A7-76A1-481F-AA77-27EC8B322544Q37269915-75E639EA-E1F1-478F-AE65-5126BAC7CCFEQ37305014-8FD401A2-2F58-4329-96EA-1EF9BF972204Q37453804-41395D11-4517-4CCF-B372-B9BB2BD561E4Q39181862-31FE122D-58BC-4087-95FE-6EF0D2340E03Q39606511-A1DA866A-DD7F-4CE9-99B0-312CDA4FA5B1Q39942987-616268D6-2E7A-4419-B307-CE1C19CED93BQ41379521-532F7888-14E2-4A85-A968-675EFC9B7717Q45871873-F2CBB8A9-A46E-4941-9DAC-AA3F581C0540Q47160989-9F61B0B2-1433-4631-B350-62701CF81533
P2860
Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Identification of the transcri ...... s for prostate cancer therapy.
@ast
Identification of the transcri ...... s for prostate cancer therapy.
@en
type
label
Identification of the transcri ...... s for prostate cancer therapy.
@ast
Identification of the transcri ...... s for prostate cancer therapy.
@en
prefLabel
Identification of the transcri ...... s for prostate cancer therapy.
@ast
Identification of the transcri ...... s for prostate cancer therapy.
@en
P2093
P1433
P1476
Identification of the transcri ...... s for prostate cancer therapy.
@en
P2093
P304
P407
P577
1999-04-01T00:00:00Z